Table 2 Main results of the cost analysis of 100 relapsing patients
| Â | Total 100-patients cohort | ||
|---|---|---|---|
Direct costs | Indirect costs | Total costs | |
Relapse diagnosis | €98,020 | n.a | €98,020 |
Locoregional relapse | €550,082 | €154,915 | €704,997 |
Metastatic relapse | €8,668,679 | €604,149 | €9,292,828 |
Characterization of the metastasis | €31,724 | n.a | €31,724 |
Distant metastases specific treatment | €414,479 | n.a | €414,479 |
1L | €7,171,435 | €451,255 | €7,622,691 |
2L | €816,838 | €101,536 | €918,375 |
3L | €196,215 | €42,356 | €238,571 |
4L +  | €57,987 | €9001 | €66,988 |
Total cost | €9,336,782 | €759,064 | €10,095,846 |